S-1: Therapeutic Solutions International Files for Resale of Up to 300 Million Shares of Common Stock

Therapeutic Solutions International (TSOI) has filed a prospectus for the resale of up to 300 million shares of its common stock by a selling shareholder, with the company potentially receiving up to $9.2 million from initial sales to GHS Investments, LLC.

Summary

• Therapeutic Solutions International, Inc. (TSOI) has filed a prospectus relating to the sale of up to 300,000,000 shares of its common stock by a selling shareholder.
• The company will not receive any proceeds from the resale of these shares.
• However, TSOI may receive up to $9,219,567.99 from the initial sale of common stock to GHS Investments, LLC, the selling shareholder, under a securities purchase agreement.
• The GHS Purchase Agreement allows TSOI to sell up to $10,000,000 of shares to GHS at its discretion within 24 months or until the $10,000,000 limit is reached.
• GHS will sell its shares at prevailing market prices or in privately negotiated transactions.
• The last reported sale price of TSOI's common stock on the OTC Markets on January 12, 2024, was $0.001 per share.
• The company's independent registered public accounting firm has included a going concern paragraph regarding its consolidated financial statements.

Sentiment

Score: 4

Explanation: The sentiment is neutral to slightly negative due to the potential for capital raising, but also the going concern warning and the risks associated with the company's stock being traded on the OTC Markets.

Positives

• The company has a potential source of funding through the securities purchase agreement with GHS Investments, LLC, which could provide up to $9.2 million in gross proceeds.

Negatives

• The company will not receive any proceeds from the resale of shares by the selling shareholder.
• The company's independent registered public accounting firm has included a going concern paragraph regarding its consolidated financial statements, indicating financial uncertainty.
• The company's stock is quoted on the OTC Pink Marketplace, which is known for thin trading and price volatility.
• The company's stock is considered a penny stock, which is subject to additional regulations and may limit trading activity.

Risks

• The company may not be able to access the full amount under the Financing Agreement.
• The company's existing stockholders may experience significant dilution from the sale of common stock pursuant to the GHS securities Purchase Agreement.
• GHS Investments LLC will pay less than the then-prevailing market price of the company's common stock which could cause the price of the common stock to decline.
• Trading on the OTC Markets may be volatile and sporadic, which could depress the market price of the company's common stock and make it difficult for stockholders to resell their shares.
• The company's stock is a penny stock, and trading of the stock may be restricted by the SEC's penny stock regulations and FINRA's sales practice requirements, which may limit a stockholder's ability to buy and sell the stock.

Future Outlook

The company intends to use the net proceeds for working capital, capital expenditures, extinguishment of debt or other liabilities, and general corporate purposes, and may also use a portion of the net proceeds to invest in or acquire businesses or technologies that it believes are complementary to its own.

Industry Context

The announcement reflects a common financing strategy for small-cap companies, particularly in the biotechnology sector, to raise capital through equity offerings. The reliance on the OTC Markets for trading is typical for companies in early stages of development.

Stakeholder Impact

• Shareholders may experience dilution due to the potential issuance of a large number of shares.
• The company's ability to execute its business plan and achieve profitability will impact its long-term viability and shareholder value.
• The company's employees and other stakeholders are subject to the risk of the company not being able to continue as a going concern.

Next Steps

• The selling shareholder will offer and sell the securities covered by the prospectus from time to time.
• The company will use the net proceeds for working capital, capital expenditures, extinguishment of debt or other liabilities, and general corporate purposes.

Key Dates

Keywords

common stock, securities purchase agreement, GHS Investments LLC, resale, Therapeutic Solutions International, TSOI, offering, shares, OTC Markets, prospectus